Ironwood Investment Counsel’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Ironwood Investment Counsel’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$2.63K	–	277
2025 Q3	$2.63K	Hold	10,000	–	–	﹤0.01%	262
2025 Q2	$1.85K	Hold	10,000	–	–	﹤0.01%	256
2025 Q1	$2.2K	Hold	10,000	–	–	﹤0.01%	240
2024 Q4	$2.1K	Sell	10,000 -2,000	-17%	-$396	﹤0.01%	246
2024 Q3	$2.51K	Hold	12,000	–	–	﹤0.01%	256
2024 Q2	$2.77K	Hold	12,000	–	–	﹤0.01%	257
2024 Q1	$10.3K	Hold	12,000	–	–	﹤0.01%	257
2023 Q4	$4.68K	Hold	12,000	–	–	﹤0.01%	253
2023 Q3	$19.2K	Buy	+12,000	New	+$33.1K	﹤0.01%	244

Ironwood Investment Counsel's RNLX Position: Q4 2025 in Review

Ironwood Investment Counsel sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2025, closing a stake of 10,000 shares — an estimated $2.63K sold.

Ironwood Investment Counsel first reported a position in RNLX in Q3 2023 and held it in 9 quarters. The position peaked at $19.2K in Q3 2023. 0 funds tracked by Wall St. Rank hold RNLX as of Q4 2025.

Ironwood Investment Counsel reported no remaining Renalytix plc American Depositary Shares position as of Q4 2025 after selling out during the quarter.
Ironwood Investment Counsel sold 10,000 Renalytix plc American Depositary Shares shares in Q4 2025, an estimated $2.63K.
Ironwood Investment Counsel first reported a position in Renalytix plc American Depositary Shares in Q3 2023 and held it in 9 quarters.
Ironwood Investment Counsel's Renalytix plc American Depositary Shares position peaked at $19.2K in Q3 2023.
0 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2025.

Based on Ironwood Investment Counsel's 13F filing for Q4 2025, filed 6 Feb 2026.